CUSIP 462222100 · who reports it, how much, and how much it matters to them
44 of the 720 hedge fund managers we track reported shares of Ionis Pharmaceuticals Inc (Nasdaq: IONS) on Form 13F for 30 June 2026. Between them they reported USD 1.7bn. The largest position belongs to Two Sigma Investments, at USD 496m. The manager with the most riding on it is Boone Capital Management, where it is 9.6% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Two Sigma Investments35 funds on PPLI.com | USD 496m | 0.4% |
| 2 | Artisan Partners1 fund on PPLI.com | USD 209m | 0.3% |
| 3 | Deep Track Capital1 fund on PPLI.com | USD 174m | 2.5% |
| 4 | Baker Bros. Advisors2 funds on PPLI.com | USD 162m | 0.8% |
| 5 | Polar Capital LLP26 funds on PPLI.com | USD 115m | 0.3% |
| 6 | Summit Partners Public Asset Management14 funds on PPLI.com | USD 62m | 1.1% |
| 7 | Eversept Partners3 funds on PPLI.com | USD 53m | 2.7% |
| 8 | Voloridge Investment Management6 funds on PPLI.com | USD 52m | 0.2% |
| 9 | Perceptive Advisors6 funds on PPLI.com | USD 45m | 0.7% |
| 10 | Renaissance Technologies13 funds on PPLI.com | USD 44m | 0.1% |
| 11 | Boone Capital Management1 fund on PPLI.com | USD 41m | 9.6% |
| 12 | Freestone Grove Partners1 fund on PPLI.com | USD 27m | 0.2% |
| 13 | Capital Fund Management S.A.12 funds on PPLI.com | USD 26m | 0.1% |
| 14 | D. E. Shaw & Co.15 funds on PPLI.com | USD 24m | 0.0% |
| 15 | Millennium Management6 funds on PPLI.com | USD 23m | 0.0% |
| 16 | Citadel Advisors32 funds on PPLI.com | USD 19m | 0.0% |
| 17 | Eagle Health Investments1 fund on PPLI.com | USD 15m | 2.6% |
| 18 | Polymer Capital Management (HK)1 fund on PPLI.com | USD 14m | 0.7% |
| 19 | Adage Capital Management1 fund on PPLI.com | USD 12m | 0.0% |
| 20 | Hudson Bay Capital Management8 funds on PPLI.com | USD 11m | 0.0% |
| 21 | Artia Global Partners1 fund on PPLI.com | USD 11m | 2.1% |
| 22 | Braidwell12 funds on PPLI.com | USD 9.3m | 0.3% |
| 23 | Squarepoint Ops7 funds on PPLI.com | USD 8.7m | 0.0% |
| 24 | Exome Asset Management2 funds on PPLI.com | USD 7m | 4.3% |
| 25 | Edgestream Partners5 funds on PPLI.com | USD 4.5m | 0.1% |
| 26 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 3.9m | 0.2% |
| 27 | Aquatic Capital Management3 funds on PPLI.com | USD 3.4m | 0.1% |
| 28 | J. Goldman & Co.1 fund on PPLI.com | USD 3.2m | 0.1% |
| 29 | Exoduspoint Capital Management7 funds on PPLI.com | USD 2.8m | 0.0% |
| 30 | Jain Global1 fund on PPLI.com | USD 2.6m | 0.0% |
| 31 | LMR Partners2 funds on PPLI.com | USD 2.4m | 0.0% |
| 32 | Wolverine Asset Management1 fund on PPLI.com | USD 1.8m | 0.0% |
| 33 | Graham Capital Management18 funds on PPLI.com | USD 1.3m | 0.0% |
| 34 | Dark Forest Capital Management2 funds on PPLI.com | USD 1.2m | 0.1% |
| 35 | Engineers Gate Manager1 fund on PPLI.com | USD 1.2m | 0.0% |
| 36 | Fora Capital1 fund on PPLI.com | USD 1.1m | 0.1% |
| 37 | Boothbay Fund Management2 funds on PPLI.com | USD 936,000 | 0.0% |
| 38 | Suvretta Capital Management4 funds on PPLI.com | USD 856,000 | 0.0% |
| 39 | Marshall Wace LLP84 funds on PPLI.com | USD 674,000 | 0.0% |
| 40 | CIBC Asset Management69 funds on PPLI.com | USD 398,000 | 0.0% |
| 41 | Voleon Capital Management13 funds on PPLI.com | USD 227,000 | 0.0% |
| 42 | Graticule Asia Macro Advisors8 funds on PPLI.com | USD 100,000 | 0.0% |
| 43 | The Quarry1 fund on PPLI.com | USD 2,299 | 0.0% |
| 44 | Walleye Capital8 funds on PPLI.com | USD 159 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Boone Capital Management | USD 41m | 9.6% |
| 2 | Exome Asset Management | USD 7m | 4.3% |
| 3 | Eversept Partners | USD 53m | 2.7% |
| 4 | Eagle Health Investments | USD 15m | 2.6% |
| 5 | Deep Track Capital | USD 174m | 2.5% |
| 6 | Artia Global Partners | USD 11m | 2.1% |
| 7 | Summit Partners Public Asset Management | USD 62m | 1.1% |
| 8 | Baker Bros. Advisors | USD 162m | 0.8% |
| 9 | Polymer Capital Management (HK) | USD 14m | 0.7% |
| 10 | Perceptive Advisors | USD 45m | 0.7% |
Ionis Pharmaceuticals Inc trades under the symbol IONS on the Nasdaq. Its CUSIP, the code used on Form 13F, is 462222100.
44 of the 720 hedge fund managers PPLI.com tracks reported Ionis Pharmaceuticals Inc shares on Form 13F for 30 June 2026. The largest reported positions were held by Two Sigma Investments (USD 496m), Artisan Partners (USD 209m), Deep Track Capital (USD 174m), Baker Bros. Advisors (USD 162m) and Polar Capital LLP (USD 115m).
44 managers in our coverage reported it, and between them they run 446 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Boone Capital Management, where the position was 9.6% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Ionis Pharmaceuticals Inc or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.